✦ LIBER ✦

A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer

✍ Scribed by Maha Hussain; Ulka Vaishampayan; Lance K. Heilbrun; Vikash Jain; Patricia M. LoRusso; Percy Ivy; Lawrence Flaherty

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Study of Rebeccamycin Analog

✍ Sanjay Goel; Scott Wadler; Anthony Hoffman; Fabio Volterra; Cheryl Baker; Elliot 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 55 KB

A Phase II Study of Depsipeptide in Refr

✍ Walter M. Stadler; Kim Margolin; Sandy Ferber; William McCulloch; John A. Thomps 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 133 KB

Becatecarin (rebeccamycin analog, NSC 65

✍ Robert W. Robey; Tomasz Obrzut; Suneet Shukla; Orsolya Polgar; Sira Macalou; Jul 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 530 KB

Phase II study of fazarabine (NSC 281272

✍ Noa Ben-Baruch; Andrea M. Denicoff; Barry R. Goldspiel; Joyce A. O'Shaughnessy; 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 323 KB

Phase II Study of Pyrazoloacridine in Me

✍ J. Philip Kuebler; Gerald W. King; Pierre Triozzi; Timothy Moore; Eric H. Kraut 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 33 KB

A Phase II Study of Thalidomide in Advan

✍ David R. Minor; Dana Monroe; Lisa A. Damico; Gloria Meng; Uma Suryadevara; Laure 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 60 KB